Interestingly, Wu et al. showed that in a human xenograft tumor model of NET, 177Lu-DOTATATE RPT led to increased infiltration of CD86+ antigen presenting cells and CD49b+/FasL+ NK cells in tumor tissues [60]. The gene discussed is CD86; the disease is neoplasm.